Beckman Coulter, Inc. — Cyborg Score 7/10

Strong
Clinical diagnostics instruments and systems

Strategic Profile

As part of Danaher's Life Sciences & Diagnostics segment, Beckman Coulter leverages the Danaher Business System for accelerated innovation and operational excellence. The company maintains market leadership through a diversified product portfolio addressing hospital laboratories, clinical diagnostics, pharmaceutical research, and biomedical research globally, with approximately 12,000+ employees and $5.8 billion in annual sales.

Cyborg Score Rationale

Beckman Coulter benefits from Danaher's operational discipline and capital access as a subsidiary, strong market position in clinical diagnostics and life sciences, diversified product lines across multiple testing disciplines, and recurring revenue from consumables and services. However, the company lacks public market autonomy and operates in a competitive landscape against well-established diagnostics players.

Top Insights

  • Subsidiary of Danaher Corporation since June 2011, providing access to world-class operational systems and technology platforms across the Life Sciences & Diagnostics segment
  • Over 12,000 employees globally with established distribution in approximately 130 countries, generating approximately $5.8 billion in annual sales with recurring revenue (consumables, services) representing ~79% of total revenue
  • Comprehensive product portfolio spanning chemistry systems, immunoassay, hematology, flow cytometry, microbiology, and laboratory automation enabling broad clinical laboratory solutions
  • Founded in 1935 with a long history of growth through acquisitions (8+ acquisitions including Olympus' diagnostics business, IRIS Diagnostics, and Cytobank), strengthening market position

Named Competitors

  • Cepheid — Molecular diagnostics and point-of-care testing systems
  • Sartorius — Bioprocess solutions and laboratory products
  • Agilent Technologies — Life sciences, diagnostics, and analytical instrumentation
  • Illumina — Next-generation DNA sequencing and genomics solutions
  • Roche Diagnostics — In vitro diagnostics and clinical laboratory instruments

Recent Developments

  • (May 2024) Introduced CytoFLEX Nano Flow Cytometer for biomedical research applications
  • (June 2019) Acquired Cytobank, a leading cloud-based flow cytometry analysis software platform

Open the full interactive Beckman Coulter, Inc. report

Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.

Open report →